Patent · US Active

EGFR dimer disruptors and use of the same

US11358965B2 · kind B2 · utility

0Cited by
2References
19Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 25, 2019
Grant dateJun 14, 2022
Priority date—
Expiry dateFeb 25, 2039

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D233/84
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

Provided herein are compounds that modulate EGFR and methods of using the same, for example to treat cancer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.